Abstract
Surface antigen analysis of leukemic blast cells with monoclonal antibodies (MoAbs) has become a routine technique for evaluating patients with acute leukemia, and contributes to the diagnosis and classification of acute myeloid leukemia’s (AML) (Drexler et al. 1988; Bain and Catovsky 1990; Cheson et al. 1990). In particular, reactivity with MoAbs recognizing myeloid antigens can assign cases of poorly differentiated leukemia to the myeloid lineage (FAB MO) (Lee et al. 1987; Bennett et al. 1991), and MoAbs reacting with platelet glycoproteins and immature erythroid cells are used to diagnose megakaryoblastic leukemia (FAB M7) and erythro-leukemia (FAB M6) (Bennett et al. 1985; San Miguel et al. 1987). Moreover, immunophenotyping identifies acute leukemia’s with both myeloid and lymphoid features, an interesting subgroup of as yet unknown prognostic significance (Cross et al. 1988; Kaplan et al. 1989; Ludwig et al. 1990; Catovsky et al. 1991).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.